Literature DB >> 15327536

Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now.

N Medalie1, A B Ackerman.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15327536     DOI： 10.1111/j.1365-2133.2004.06132.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  9 in total

1.  Sentinel lymph node biopsy in melanoma management: its significance and potential problems.

Authors:  Toshiaki Saida
Journal:  Int J Clin Oncol       Date:  2009-12-05       Impact factor: 3.402

2.  Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma.

Authors:  Laura Calomarde-Rees; Rosario García-Calatayud; Celia Requena Caballero; Esperanza Manrique-Silva; Víctor Traves; Zaida García-Casado; Virtudes Soriano; Rajiv Kumar; Eduardo Nagore
Journal:  JAMA Dermatol       Date:  2019-06-01       Impact factor: 10.282

3.  Clinicopathologic prognostic markers of survival: an analysis of 259 patients with malignant melanoma >or=1 mm.

Authors:  Friederike Egberts; A Momkvist; J H Egberts; K C Kaehler; M Weichenthal; A Hauschild
Journal:  Tumour Biol       Date:  2009-12-18

4.  Time course and pattern of metastasis of cutaneous melanoma differ between men and women.

Authors:  Liljana Mervic
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

5.  Letter to the editor.

Authors:  Ricardo E Achenbach
Journal:  Dermatol Pract Concept       Date:  2011-01-31

Review 6.  Controversies in the diagnosis and treatment of early cutaneous melanoma.

Authors:  O A Orzan; A Șandru; C R Jecan
Journal:  J Med Life       Date:  2015 Apr-Jun

7.  Head and neck cutaneous melanoma: 5-year survival analysis in a Serbian university center.

Authors:  Aleksandar Višnjić; Predrag Kovačević; Asen Veličkov; Mariola Stojanović; Stefan Mladenović
Journal:  World J Surg Oncol       Date:  2020-11-29       Impact factor: 2.754

8.  Risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma.

Authors:  Alexandra S Berghe; Gheorghe Cobzac; George Dindelegan; Simona C Șenilă; Corina I Baican; Carolina M Solomon; Liliana Rogojan; Daniel C Leucuța; Tudor C Drugan; Sorana D Bolboacă
Journal:  Exp Ther Med       Date:  2021-05-05       Impact factor: 2.447

9.  Sentinel lymph node biopsy for cutaneous melanoma: a 6 years study.

Authors:  Jaime Lima Sánchez; M Sánchez Medina; O García Duque; M Fiúza Pérez; G Carreteri Hernández; J Fernández Palácios
Journal:  Indian J Plast Surg       Date:  2013-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.